These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 32067620

  • 21. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.
    He XX, Zhang YN, Yan JW, Yan JJ, Wu Q, Song YH.
    Tumour Biol; 2016 Jan; 37(1):807-15. PubMed ID: 26250460
    [Abstract] [Full Text] [Related]

  • 22. Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line.
    Murthy SS, Narsaiah TB.
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1873-1897. PubMed ID: 33735410
    [Abstract] [Full Text] [Related]

  • 23. In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249.
    Shi H, Lambert JM, Hautefeuille A, Bykov VJ, Wiman KG, Hainaut P, Caron de Fromentel C.
    Carcinogenesis; 2008 Jul; 29(7):1428-34. PubMed ID: 18048389
    [Abstract] [Full Text] [Related]

  • 24. A new triterpenoid from Panax ginseng exhibits cytotoxicity through p53 and the caspase signaling pathway in the HepG2 cell line.
    Huang J, Tang XH, Ikejima T, Sun XJ, Wang XB, Xi RG, Wu LJ.
    Arch Pharm Res; 2008 Mar; 31(3):323-9. PubMed ID: 18409045
    [Abstract] [Full Text] [Related]

  • 25. Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
    Hui IC, Tung EK, Sze KM, Ching YP, Ng IO.
    Liver Int; 2010 Jan; 30(1):65-75. PubMed ID: 19845851
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53.
    Peng W, Hu C, Shu Z, Han T, Qin L, Zheng C.
    Phytomedicine; 2015 Jul 15; 22(7-8):730-6. PubMed ID: 26141759
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E, Lee KY.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):771-9. PubMed ID: 14975768
    [Abstract] [Full Text] [Related]

  • 30. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
    Sharula, Wu Z.
    Anticancer Agents Med Chem; 2017 Mar 12; 17(7):941-947. PubMed ID: 28356025
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
    Hong M, Almutairi MM, Li S, Li J.
    Phytomedicine; 2020 Mar 12; 68():153174. PubMed ID: 31991293
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
    Sbenati RM, Zaraei SO, El-Gamal MI, Anbar HS, Tarazi H, Zoghbor MM, Mohamood NA, Khakpour MM, Zaher DM, Omar HA, Alach NN, Shehata MK, El-Gamal R.
    Eur J Med Chem; 2021 Jan 15; 210():113081. PubMed ID: 33310290
    [Abstract] [Full Text] [Related]

  • 37. The cytotoxic and mechanistic effects of aaptamine on hepatocellular carcinoma.
    Li QL, Zhang PP, Wang PQ, Yu HB, Sun F, Hu WZ, Wu WH, Zhang X, Chen F, Chu ZY, Zhang JP, Chen SS, Lin HW.
    Anticancer Agents Med Chem; 2015 Jan 15; 15(3):291-7. PubMed ID: 25403168
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. EFLDO sensitizes liver cancer cells to TNFSF10‑induced apoptosis in a p53‑dependent manner.
    Qu Y, Liao Z, Wang X, Zhang J, Liu C.
    Mol Med Rep; 2019 May 15; 19(5):3799-3806. PubMed ID: 30896802
    [Abstract] [Full Text] [Related]

  • 40. Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression.
    Yang P, Jiang Y, Pan Y, Ding X, Rhea P, Ding J, Hawke DH, Felsher D, Narla G, Lu Z, Lee RT.
    Sci Rep; 2019 Apr 23; 9(1):6428. PubMed ID: 31015523
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.